The FDA is testing real-time clinical trial reporting in an effort to speed up the drug review and approval process.

The FDA plans to expedite the review process for three psychedelic drugs aimed at treating mental health issues, following ...

Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental ...

FDA commissioner Marty Makary told NBC News that the first psychedelic drug could be approved in the U.S. as soon as this ...

Passage Bio initiated a strategic review process after regulators didn't support a single-arm trial design for its dementia drug. The Food and Drug Administration indicated a randomized controlled ...

The Food and Drug Administration is a government agency that regulates certain food, drugs, cosmetics, and medical products.